Dr. Ira Dunkel, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
14 reported clinical trials
27 drugs studied
Area of expertise
1Brain Tumor
H3K27M positive
Stage III
Stage IV
2Diffuse Intrinsic Pontine Glioma
H3K27M positive
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Ira Dunkel, MD is currently running
CAR T Cell Therapy
for Ependymoma
This is a Phase I study to evaluate the safety profile of a type of immune therapy called HER2 CAR T cells (short for HER2 chimeric antigen receptor T cells). In addition to looking for side effects, we will study how well this treatment works against a brain tumor called ependymoma that has come back after treatment (recurrent) or has not responded well to treatment (progressive) in children. The HER2 CAR T cells used in this trial are made from the patient's own blood. A new gene, called the HER2 CAR, will be inserted into patient's T cells to allow them recognize a protein on the tumor called HER2. These HER2-specific CAR T cells may be able to target and kill ependymoma tumors that express HER2. This research is also studying how doable it is to provide this type of CAR T cell treatment to children being treated at different hospitals.
Recruiting1 award Phase 1
Savolitinib
for Brain Tumors
This phase I trial studies the side effects and best dose of volitinib in treating patients with primary central nervous system (CNS) tumors that have come back (recurrent) or does not respond to treatment (refractory). Volitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 1
More about Ira Dunkel, MD
Clinical Trial Related8 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Ira Dunkel, MD has experience with
- Prednisone
- Mercaptopurine
- Methotrexate
- Cytosine Arabinoside
- Vinblastine
- INDOMETHACIN
Breakdown of trials Ira Dunkel, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Ependymoma
Medulloblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ira Dunkel, MD specialize in?
Ira Dunkel, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved H3K27M positive patients, or patients who are Stage III.
Is Ira Dunkel, MD currently recruiting for clinical trials?
Yes, Ira Dunkel, MD is currently recruiting for 7 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Ira Dunkel, MD has studied deeply?
Yes, Ira Dunkel, MD has studied treatments such as Prednisone, Mercaptopurine, Methotrexate.
What is the best way to schedule an appointment with Ira Dunkel, MD?
Apply for one of the trials that Ira Dunkel, MD is conducting.
What is the office address of Ira Dunkel, MD?
The office of Ira Dunkel, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.